Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37 - PubMed (original) (raw)

Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37

L G Perez et al. J Virol. 1987 May.

Abstract

We have investigated the specificity of the proteolytic cleavage of the Rous sarcoma virus glycoprotein precursor by introducing two mutations into the putative cleavage region (Arg-Arg-Lys-Arg). We show that neither a deletion of the cleavage sequence nor a glutamic acid for lysine substitution altered intracellular transport or surface expression of the env gene products. However, both the four-amino-acid deletion and the glutamic acid substitution block processing of the env precursor. Susceptibility of the glutamic acid-substituted env precursor to proteases indicated that tertiary protein structure was unaffected. While inhibitor experiments suggested that more than one endopeptidase might be capable of mediating the proteolytic cleavage, the results presented here point to the presence in the Golgi apparatus of a novel endopeptidase, required for retroviral glycoprotein cleavage, that has a high specificity for lysine-containing peptides.

PubMed Disclaimer

References

1. Virology. 1971 Dec;46(3):830-43 - PubMed
1. Cell. 1986 May 9;45(3):375-85 - PubMed
1. Lancet. 1972 Oct 14;2(7781):797-9 - PubMed
1. J Biol Chem. 1973 Jul 10;248(13):4544-51 - PubMed
1. Virology. 1974 Jan;57(1):28-41 - PubMed

Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37 - PubMed (original) (raw)